4,10-dihydro-5H-thieno[3,2-c][1]benzazepine derivatives and 9,10-dihydro-4H-thieno[2,3-c][1]benzazepine derivatives as orally active arginine vasopressin receptor antagonists

Bioorg Med Chem Lett. 1999 Jul 5;9(13):1733-6. doi: 10.1016/s0960-894x(99)00278-4.

Abstract

Synthesis and structure-activity relationships (SAR) of arginine vasopressin receptor (AVP) antagonists are described. Potent and orally active compounds are prepared when tricyclic 10,11-dihydro-5H-pyrrolo[2,1-c][1,4]benzodiazepine moiety in VPA-985 1 is replaced with a compound 7 or 12.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Animals
  • Antidiuretic Hormone Receptor Antagonists*
  • Azepines / chemical synthesis*
  • Azepines / pharmacology*
  • Benzamides / chemical synthesis*
  • Benzamides / pharmacology*
  • Benzazepines / chemical synthesis*
  • Benzazepines / pharmacology
  • Fibroblasts
  • Inhibitory Concentration 50
  • Mice
  • Pyrroles
  • Structure-Activity Relationship
  • Thiophenes / chemical synthesis*
  • Thiophenes / pharmacology

Substances

  • 5-(((2-chloro-4-(5-fluoro-2-methylphenyl)carbonylamino)phenyl)carbonyl)-9,10-dihydro-4H-thieno(2,3-c)(1)benzazepine
  • 5-((4-((2-methylphenyl)carbonylamino)phenyl)carbonyl)-4,10-dhydro-5H-thieno(3,2-c)(1)benzazepine
  • Antidiuretic Hormone Receptor Antagonists
  • Azepines
  • Benzamides
  • Benzazepines
  • Pyrroles
  • Thiophenes
  • lixivaptan